Page last updated: 2024-08-17

medroxyprogesterone acetate and Female Genitourinary Diseases

medroxyprogesterone acetate has been researched along with Female Genitourinary Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Crandall, CJ; Manson, JE; Mehta, JM1
Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S1

Reviews

1 review(s) available for medroxyprogesterone acetate and Female Genitourinary Diseases

ArticleYear
Management of Menopausal Symptoms: A Review.
    JAMA, 2023, 02-07, Volume: 329, Issue:5

    Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism

2023

Trials

1 trial(s) available for medroxyprogesterone acetate and Female Genitourinary Diseases

ArticleYear
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:1

    Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain

2002